Polyrizon commences gmp manufacturing preliminary process for its pl-14 allergy blocker in preparation for planned 2025 clinical trial

Eurofins cdmo amatsiaquitaine s.a.s., the gmp manufacturer, to support polyrizon in future commercialization efforts raanana, israel, jan. 23, 2025 (globe newswire) -- polyrizon ltd.

PLRZ Ratings Summary

PLRZ Quant Ranking